Empowered Funds’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-191,341
Closed -$2.67M 1391
2023
Q4
$2.67M Buy
191,341
+4,294
+2% +$59.6K 0.07% 416
2023
Q3
$2.76M Buy
187,047
+3,070
+2% +$43.2K 0.08% 345
2023
Q2
$2.38M Buy
183,977
+107,405
+140% +$1.22M 0.08% 342
2023
Q1
$751K Buy
+76,572
New +$817K 0.04% 346

Other funds holding DVAX

Empowered Funds's DVAX Position: Q1 2024 in Review

Empowered Funds sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 191,341 shares — an estimated $2.67M sold.

Empowered Funds first reported a position in DVAX in Q1 2023 and held it in 4 quarters. The position peaked at $2.76M in Q3 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • Empowered Funds reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • Empowered Funds sold 191,341 Dynavax Technologies shares in Q1 2024, an estimated $2.67M.
  • Empowered Funds first reported a position in Dynavax Technologies in Q1 2023 and held it in 4 quarters.
  • Empowered Funds's Dynavax Technologies position peaked at $2.76M in Q3 2023.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on Empowered Funds's 13F filing for Q1 2024, filed 6 May 2024.